| 生物活性 | |||
|---|---|---|---|
| 描述 | NCGC00229600 is characterized as an allosteric inverse agonist for the thyrotropin receptor (TSHR), effectively inhibiting the activation of TSHRs by both thyroid-stimulating hormone (TSH) and stimulating antibodies found in Graves' disease. This highlights its potential for therapeutic applications in treating conditions related to thyroid dysfunction[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.09mL 0.42mL 0.21mL | 10.43mL 2.09mL 1.04mL | 20.85mL 4.17mL 2.09mL | 
| 参考文献 | 
|---|